These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34364181)

  • 1. Introduction of digital therapeutics.
    Hong JS; Wasden C; Han DH
    Comput Methods Programs Biomed; 2021 Sep; 209():106319. PubMed ID: 34364181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.
    Kim SY; Moon JY; Shin J; Sim JY; Kim M; Jang J
    Yonsei Med J; 2022 Jan; 63(Suppl):S56-S62. PubMed ID: 35040606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital therapeutics and the need for regulation: how to develop products that are innovative, patient-centric and safe.
    Rassi-Cruz M; Valente F; Caniza MV
    Diabetol Metab Syndr; 2022 Apr; 14(1):48. PubMed ID: 35365189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Download to Heal: Navigating the Pixelated Path of Digital Therapeutics in Psychiatric Care.
    Ahuja J; Jaka S; Saeed S; Gunturu S
    Braz J Psychiatry; 2024 Sep; ():. PubMed ID: 39329484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate.
    Watson A; Chapman R; Shafai G; Maricich YA
    Front Digit Health; 2023; 5():1086219. PubMed ID: 37139487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating digital therapeutics for mental health: Opportunities, challenges, and the essential role of psychologists.
    Carl JR; Jones DJ; Lindhiem OJ; Doss BD; Weingardt KR; Timmons AC; Comer JS
    Br J Clin Psychol; 2022 Jan; 61 Suppl 1():130-135. PubMed ID: 33650131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
    Bennett CL; Schoen MW; Hoque S; Witherspoon BJ; Aboulafia DM; Hwang CS; Ray P; Yarnold PR; Chen BK; Schooley B; Taylor MA; Wyatt MD; Hrushesky WJ; Yang YT
    Lancet Oncol; 2020 Dec; 21(12):e575-e588. PubMed ID: 33271114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital therapeutics in the clinic.
    Phan P; Mitragotri S; Zhao Z
    Bioeng Transl Med; 2023 Jul; 8(4):e10536. PubMed ID: 37476062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the potential of digital therapeutics: An assessment of progress and promise.
    Armeni P; Polat I; De Rossi LM; Diaferia L; Meregalli S; Gatti A
    Digit Health; 2024; 10():20552076241277441. PubMed ID: 39291152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.
    Nomura A
    Hypertens Res; 2023 Sep; 46(9):2126-2134. PubMed ID: 37258624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of blended care as a mechanism of action in the construction of digital therapeutics.
    Valerio Netto A
    Einstein (Sao Paulo); 2020; 18():eMD5640. PubMed ID: 33237249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders.
    Afra P; Bruggers CS; Sweney M; Fagatele L; Alavi F; Greenwald M; Huntsman M; Nguyen K; Jones JK; Shantz D; Bulaj G
    Front Hum Neurosci; 2018; 12():171. PubMed ID: 29780310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Digital Therapeutics Are Urging the Need for a Paradigm Shift: From Evidence-Based Health Care to Evidence-Based Well-being.
    Smits M; Ludden GDS; Verbeek PP; van Goor H
    Interact J Med Res; 2022 Oct; 11(2):e39323. PubMed ID: 36264624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Metaverse for Healthcare: Trends, Applications, and Future Directions of Digital Therapeutics for Urology.
    Kim EJ; Kim JY
    Int Neurourol J; 2023 May; 27(Suppl 1):S3-12. PubMed ID: 37280754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies Of Prescription Digital Therapeutics Often Lack Rigor And Inclusivity.
    Kumar A; Ross JS; Patel NA; Rathi V; Redberg RF; Dhruva SS
    Health Aff (Millwood); 2023 Nov; 42(11):1559-1567. PubMed ID: 37931187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development.
    Sverdlov O; van Dam J; Hannesdottir K; Thornton-Wells T
    Clin Pharmacol Ther; 2018 Jul; 104(1):72-80. PubMed ID: 29377057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Need for Artificial Intelligence in Digital Therapeutics.
    Palanica A; Docktor MJ; Lieberman M; Fossat Y
    Digit Biomark; 2020; 4(1):21-25. PubMed ID: 32399513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.